scholarly journals The role of digital rectal examination in presence of low PSA levels

2021 ◽  
Vol 32 ◽  
pp. S46
Author(s):  
M. Podagrosi ◽  
C. Fede Spicchiale ◽  
P. Pacini ◽  
S. Pletto ◽  
S. Pastore ◽  
...  
2006 ◽  
Vol 5 (2) ◽  
pp. 202
Author(s):  
V. Serretta ◽  
A. Galuffo ◽  
A. Catanese ◽  
R. Allegro ◽  
R. Ascoli ◽  
...  

2015 ◽  
Vol 21 (1) ◽  
pp. 111 ◽  
Author(s):  
Jane Crowe ◽  
Addie C. Wootten ◽  
Nicholas Howard

The role of the General Practitioner (GP) in testing for and managing men with prostate cancer (PCa) is significant. Very few studies have explored the attitudes and practices of Australian GPs in the context of the role of PCa testing. In this study, a 46-item web-based questionnaire was used to assess self-reported PCa testing attitudes and practices of GPs. This questionnaire was circulated to divisions of general practice and Medicare locals for further distribution to their GP members across Australia. GPs from all states and territories participated, and a total of 136 GPs completed the survey. Of the responding GPs, 57% always or usually offered PCa testing to asymptomatic men ≤70 years of age and 60% of GPs always or usually included a digital rectal examination (DRE). Many (80%) of the GPs stated that the current PCa testing guidelines were not clear. PCa testing was offered opportunistically by 56% while 39% offered testing at the patient’s request. The results captured in this study represent a snapshot of GP attitudes and practices from across Australia. The results presented indicate a wide variation in the approaches to PCa testing in general practice across Australia, which in most part appear to be related to the lack of clarity of the current prostate cancer testing guidelines.


2007 ◽  
Vol 177 (4S) ◽  
pp. 337-338
Author(s):  
Claudio Jeldres ◽  
Sascha Ahyai ◽  
Andrea Gallina ◽  
Jochen Walz ◽  
Thomas Steuber ◽  
...  

2005 ◽  
Vol 72 (4) ◽  
pp. 440-442
Author(s):  
A. Galuffo ◽  
V. Serretta ◽  
L. Di Gregorio ◽  
F. Scuto ◽  
V. Bertolino ◽  
...  

Subclinical infections of the prostate can increase the prostate-specific antigen (PSA) values in patients with normal digital rectal examination. This study aimed to evaluate the role of short-term antimicrobial therapy in reducing the PSA value in patients as candidates for transrectal biopsy. Fifty-eight patients with negative digital rectal examination and PSA values between 4 and 20 ng/mL were included in the study. Antibiotics were administered to all patients for 3 weeks, and the PSA was reassessed 10 days after the end of the treatment. Patients were subsequently submitted to prostate biopsy. A reduction in PSA was detected in 34 patients (59%). Mean percentage reduction was 32%. In only six patients (10%) did the PSA return to normal levels. Prostate biopsy revealed prostate cancer in 26 patients (45%). Prostate cancer was not detected in patients with PSA levels above 4 ng/mL. Prostate biopsy can be avoided only in a small number of patients showing the normalization of PSA levels after short-term antimicrobial therapy. These patients should be strictly monitored with frequent PSA determinations.


2012 ◽  
Vol 61 (3) ◽  
pp. 577-583 ◽  
Author(s):  
Monique J. Roobol ◽  
Heidi A. van Vugt ◽  
Stacy Loeb ◽  
Xiaoye Zhu ◽  
Meelan Bul ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document